Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Human Hepatocellular Carcinoma Metabolism: Imaging by Hyperpolarized 13C Magnetic Resonance Spectroscopy.

Darpolor MM, Kaplan DE, Pedersen PL, Glickson JD.

J Liver Disease Transplant. 2012 Sep 1;1(1). doi: 10.4172/2325-9612.1000101.

2.

Hyperpolarized α-keto[1-13C]isocaproate as a 13C magnetic resonance spectroscopic agent for profiling branched chain amino acid metabolism in tumors.

Shan L.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2010 Jan 15 [updated 2010 May 19].

3.

Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.

Menzel MI, Farrell EV, Janich MA, Khegai O, Wiesinger F, Nekolla S, Otto AM, Haase A, Schulte RF, Schwaiger M.

J Nucl Med. 2013 Jul;54(7):1113-9. doi: 10.2967/jnumed.112.110825. Epub 2013 Apr 17.

4.

Hyperpolarized [1-13C]dehydroascorbic acid.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 Sep 15 [updated 2011 Dec 15].

5.

The use of dynamic nuclear polarization (13)C-pyruvate MRS in cancer.

Gutte H, Hansen AE, Johannesen HH, Clemmensen AE, Ardenkjær-Larsen JH, Nielsen CH, Kjær A.

Am J Nucl Med Mol Imaging. 2015 Oct 12;5(5):548-60. eCollection 2015. Review.

6.

In vivo carbon-13 dynamic MRS and MRSI of normal and fasted rat liver with hyperpolarized 13C-pyruvate.

Hu S, Chen AP, Zierhut ML, Bok R, Yen YF, Schroeder MA, Hurd RE, Nelson SJ, Kurhanewicz J, Vigneron DB.

Mol Imaging Biol. 2009 Nov-Dec;11(6):399-407. doi: 10.1007/s11307-009-0218-z. Epub 2009 May 8.

7.

Metabolic imaging by hyperpolarized 13C magnetic resonance imaging for in vivo tumor diagnosis.

Golman K, Zandt RI, Lerche M, Pehrson R, Ardenkjaer-Larsen JH.

Cancer Res. 2006 Nov 15;66(22):10855-60.

8.

Feasibility of using hyperpolarized [1-13C]lactate as a substrate for in vivo metabolic 13C MRSI studies.

Chen AP, Kurhanewicz J, Bok R, Xu D, Joun D, Zhang V, Nelson SJ, Hurd RE, Vigneron DB.

Magn Reson Imaging. 2008 Jul;26(6):721-6. doi: 10.1016/j.mri.2008.01.002. Epub 2008 May 13.

9.

Hyperpolarized [1,3-13C2 ]ethyl acetoacetate is a novel diagnostic metabolic marker of liver cancer.

Jensen PR, Serra SC, Miragoli L, Karlsson M, Cabella C, Poggi L, Venturi L, Tedoldi F, Lerche MH.

Int J Cancer. 2015 Feb 15;136(4):E117-26. doi: 10.1002/ijc.29162. Epub 2014 Sep 4.

10.

Hyperpolarized (13)C-lactate to (13)C-bicarbonate ratio as a biomarker for monitoring the acute response of anti-vascular endothelial growth factor (anti-VEGF) treatment.

Park JM, Spielman DM, Josan S, Jang T, Merchant M, Hurd RE, Mayer D, Recht LD.

NMR Biomed. 2016 May;29(5):650-9. doi: 10.1002/nbm.3509. Epub 2016 Mar 14.

PMID:
26990457
11.

Reduced Warburg effect in cancer cells undergoing autophagy: steady- state 1H-MRS and real-time hyperpolarized 13C-MRS studies.

Lin G, Andrejeva G, Wong Te Fong AC, Hill DK, Orton MR, Parkes HG, Koh DM, Robinson SP, Leach MO, Eykyn TR, Chung YL.

PLoS One. 2014 Mar 25;9(3):e92645. doi: 10.1371/journal.pone.0092645. eCollection 2014.

12.

Tumor imaging using hyperpolarized 13C magnetic resonance spectroscopy.

Brindle KM, Bohndiek SE, Gallagher FA, Kettunen MI.

Magn Reson Med. 2011 Aug;66(2):505-19. doi: 10.1002/mrm.22999. Epub 2011 Jun 9. Review.

13.

Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading.

Albers MJ, Bok R, Chen AP, Cunningham CH, Zierhut ML, Zhang VY, Kohler SJ, Tropp J, Hurd RE, Yen YF, Nelson SJ, Vigneron DB, Kurhanewicz J.

Cancer Res. 2008 Oct 15;68(20):8607-15. doi: 10.1158/0008-5472.CAN-08-0749.

14.

13C MR spectroscopy measurements of glutaminase activity in human hepatocellular carcinoma cells using hyperpolarized 13C-labeled glutamine.

Gallagher FA, Kettunen MI, Day SE, Lerche M, Brindle KM.

Magn Reson Med. 2008 Aug;60(2):253-7. doi: 10.1002/mrm.21650.

15.

miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma.

Liu AM, Xu Z, Shek FH, Wong KF, Lee NP, Poon RT, Chen J, Luk JM.

PLoS One. 2014 Jan 23;9(1):e86872. doi: 10.1371/journal.pone.0086872. eCollection 2014.

16.

In vivo measurement of ethanol metabolism in the rat liver using magnetic resonance spectroscopy of hyperpolarized [1-13C]pyruvate.

Spielman DM, Mayer D, Yen YF, Tropp J, Hurd RE, Pfefferbaum A.

Magn Reson Med. 2009 Aug;62(2):307-13. doi: 10.1002/mrm.21998.

17.

Development and applications of in vivo clinical magnetic resonance spectroscopy.

Cox IJ.

Prog Biophys Mol Biol. 1996;65(1-2):45-81. Review.

PMID:
9029941
18.

EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3-bromopyruvate.

Matsumoto S, Saito K, Yasui H, Morris HD, Munasinghe JP, Lizak M, Merkle H, Ardenkjaer-Larsen JH, Choudhuri R, Devasahayam N, Subramanian S, Koretsky AP, Mitchell JB, Krishna MC.

Magn Reson Med. 2013 May;69(5):1443-50. doi: 10.1002/mrm.24355. Epub 2012 Jun 12.

19.

Simultaneous hyperpolarized (13)C-pyruvate MRI and (18)F-FDG-PET in cancer (hyperPET): feasibility of a new imaging concept using a clinical PET/MRI scanner.

Gutte H, Hansen AE, Henriksen ST, Johannesen HH, Ardenkjaer-Larsen J, Vignaud A, Hansen AE, Børresen B, Klausen TL, Wittekind AM, Gillings N, Kristensen AT, Clemmensen A, Højgaard L, Kjær A.

Am J Nucl Med Mol Imaging. 2014 Dec 15;5(1):38-45. eCollection 2015.

20.

Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective.

Poon RT, Fan ST, Tsang FH, Wong J.

Ann Surg. 2002 Apr;235(4):466-86. Review.

Items per page

Supplemental Content

Write to the Help Desk